15 junio 2015
A protein that targets the effects of a faulty gene could offer the first treatment targeting the major genetic cause of Pulmonary Arterial Hypertension (PAH), according to new research.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/YgBTgHWH0bU/150615125247.htm
